Carson Wealth (CWM LLC)
FENC icon

Carson Wealth (CWM LLC)’s Fennec Pharmaceuticals FENC Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.54K Buy
1,063
+313
+42% +$2.42K ﹤0.01% 4938
2025
Q4 		$6K Sell
750
-61
-8% -$501 ﹤0.01% 4741
2025
Q3 		$8K Buy
811
+14
+2% +$121 ﹤0.01% 4558
2025
Q2 		$7K Buy
797
+310
+64% +$2.12K ﹤0.01% 4444
2025
Q1 		$3K Buy
487
+230
+89% +$1.48K ﹤0.01% 4619
2024
Q4 		$2K Buy
257
+128
+99% +$656 ﹤0.01% 4532
2024
Q3 		$1K Buy
129
+92
+249% +$532 ﹤0.01% 4579
2024
Q2 		$0 Buy
37
+29
+363% +$241 ﹤0.01% 4692
2024
Q1 		$0 Buy
+8
New +$80 ﹤0.01% 4452

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Carson Wealth (CWM LLC)'s FENC Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Fennec Pharmaceuticals (FENC) stake by 42% in Q1 2026, buying an estimated $2.42K and bringing the position to 1,063 shares worth $6.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4938.

Carson Wealth (CWM LLC) first reported a position in FENC in Q1 2024 and has held it in 9 quarters since. The position peaked at $8K in Q3 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,063 shares of Fennec Pharmaceuticals worth $6.54K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 313 Fennec Pharmaceuticals shares in Q1 2026, an estimated $2.42K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4938 holding.
  • Carson Wealth (CWM LLC) first reported a position in Fennec Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Fennec Pharmaceuticals position peaked at $8K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.